Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study
| Autor: | Micheline Gagné, Louis Prud’homme, Vincent Pichette, Denis Ouimet, Alain Bonnardeaux, J. Cardinal |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
musculoskeletal diseases
Adult Male medicine.medical_specialty Time Factors Bone disease Osteoporosis Urology Lumbar Prednisone Bone Density Risk Factors medicine Prevalence Humans Longitudinal Studies Glucocorticoids Bone mineral business.industry Middle Aged medicine.disease Kidney Transplantation Surgery Osteopenia Transplantation Bone Diseases Metabolic Cross-Sectional Studies Nephrology Spinal Fractures Female Densitometry business medicine.drug Follow-Up Studies |
| Zdroj: | American journal of kidney diseases : the official journal of the National Kidney Foundation. 28(1) |
| ISSN: | 0272-6386 |
| Popis: | Organ transplantation is associated with an early bone loss that subsequently increases the risk of osteopenia and bone fractures. It is not known whether bone loss continues in long-term survivors, but persistent bone demineralization could further jeopardize an already diminished bone mass. To better define long-term bone status of kidney transplant recipients (KTR), we conducted cross-sectional and longitudinal evaluations of bone mineral density (BMD) in 70 KTR with a mean posttransplantation time of 8.1 years. BMD was determined by dual-energy X-ray absorptiometry and was repeated in 55 of the patients after a mean follow-up period of 22 +/- 5 months. Lumbar and femoral osteopenia, defined as a BMD lower than 2 standard deviations from mean value of sex- and age-matched controls, was present in 28.6% and 10.5% of patients, respectively. There was a significant negative correlation between cumulative prednisone dose and adjusted lumbar as well as femoral BMD (R = 0.45, P0.001 and R = 0.29, P0.05, respectively). Five patients had a vertebral BMD below a fracture threshold of 0.777 g/cm2. Vertebral fractures (VF) were found in four men and were associated with higher prednisone dosage (P0.05), larger cumulative prednisone dose (P0.05), and significantly lower BMD values. According to World Health Organization recent criteria for women, prevalences of lumbar and femoral osteopenia and lumbar and femoral osteoporosis in female patients reach 75%, 65%, 33%, and 10%, respectively. The longitudinal part of the study showed a persistent pathological lumbar demineralization process. Over the study period, BMD, expressed as a percentage of that of controls, decreased from 89 +/- 14% to 86 +/- 14% (P0.001). Annual change of bone mass was -1.7 +/- 2.8% per year. Accelerated vertebral bone loss (defined as a decrease of BMD, expressed as a percentage of that of controls, of more than 1% per year) was present in 56% of patients and was associated with higher prednisone dosage (P0.01). In conclusion, although VF are relatively infrequent in long-term survivors of renal transplantation, osteopenia is a frequent finding, and a substantial proportion of women present lumbar osteoporosis. An ongoing demineralization process of the spine is also demonstrated and probably contributes to long-term spinal osteoporosis incidence. Prednisone dosage remains the most constantly isolated risk factor. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|